chrisvoncsefalvay/vaers-outcomes huggingface dataset:
SYMPTOMS-UNRESPONSIVE TREATMENT- AMMONIA INHALANT, ICE PACK, FEET ELEVATED OUTCOME- FELT FINE
got pretty sick; felt like the flu; felt pretty bad; had fever; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (got pretty sick), INFLUENZA LIKE ILLNESS (felt like the flu), FEELING ABNORMAL (felt pretty bad) and PYREXIA (had fever) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes (underlying condition).   In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In April 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ILLNESS (got pretty sick), INFLUENZA LIKE ILLNESS (felt like the flu), FEELING ABNORMAL (felt pretty bad) and PYREXIA (had fever). At the time of the report, ILLNESS (got pretty sick), INFLUENZA LIKE ILLNESS (felt like the flu) and FEELING ABNORMAL (felt pretty bad) outcome was unknown and PYREXIA (had fever) had resolved.            No concomitant medication information was provided. No treatment medication information was provided. This case pertains to patient 2. Patient got pretty sick after the  second Moderna dose. They felt like the flu, they felt pretty bad, and had fever, for 3 days.   This case was linked to MOD-2021-272492 (Patient Link).
vomiting; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (vomiting) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     no medical history was provided.     On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced VOMITING (vomiting). At the time of the report, VOMITING (vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medication was reported , No treatment medication was reported .   Reporter did not allow further contact
Redness and swelling around vaccine injection site started few hours after vaccine and worsened over following 2 days until entire left upper extremity was tense and swollen down to elbow, and surface of skin had very small tense fluid-filled blisters.  Patient was treated with oral prednisone and the following day has noted significant improvement with resolution of redness, decreased swelling, and resolution of blisters.
Child received a second Varicella immunization and approximately 10 to 15 minutes later started to whimper and experienced an episode resulting on his falling to the floor.  It appeared he possibly was having a seizure.  His eyes were open, his back slightly arched and appeared to be posturing.  He did not respond to verbal command but immediately snapped out of the episode when touched.  The episode lasted approximately 30 seconds.
the inadvertent administration ofan expired dose of ROTATEQ; This spontaneous report was received from a nurse via a company representative and refers to a 4-month-old patient of unknown gender. The patient's pertinent medical history, concurrent conditions and concomitant medications were not reported.  On 16-OCT-2019, the patient was vaccinated with an expired rotavirus vaccine, live, oral, pentavalent (ROTATEQ), lot # R002806, expiration date 29-SEP-2019, orally (dose was not reported) for prophylaxis.
Pt had reaction of redness and swelling to injection site. Second day of reaction increased swelling at injection site as well and lymph nodes in this arm swollen. Also stated it was hard, warm and swollen.
This spontaneous report as received from a medical assistant refers to an unspecified number patient of unknown age. the patients' pertinent medical history, drug reactions/allergies and concomitant medication were not reported. On an unknown date, the patient was vaccinated with improperly stored PROQUAD (lot # M007960, expiry date 15-AUG-2017 or lot# M011663, expiry date 08-SEP-2017) subcutaneous. No adverse effects were reported. This is one of the two reports received from the same reporter. Additional information has been requested.
4/9/21 before 8am -  coughed up large amounts of blood, went to ER at hospital several hours later. Admitted to the hospital for 4 days after finding blood clots in the lungs.
Information has been received from a consumer concerning his currently 3 1/2 year old daughter with no pertinent medical history and no drug reactions/allergies, who at approximately 11 months old (in approximately 2004) was vaccinated with a single dose of MMR II. Concomitant therapy included "a number of other vaccines" (therapy unspecified) (manufacturer unknown). It was noted that on the day of vaccination the patient took her very first walking steps, however, later that evening that the patient had difficulty sleeping and she was screaming. He stated that her behavior became more and more abnormal, she continued to have difficulty sleeping and became hyperactive. The consumer indicated that his daughter would not make eye contact and would run out of a room for no apparent reason. He stated that the patient seemed to have no fears or feelings and would do things such as running into walls. Subsequently the patient was diagnosed with autism. No  physician information was provided. Lab diagnostic studies performed included "psychiatric evaluation and tests". The outcome was reported as not recovered. There was no product quality complaint. Upon internal review the patient's autism was determined to be an other important medical event. Additional information has been requested.
Information has been received for the Merck Pregnancy Registry from a nurse concerning a female (age not reported) who on an unspecified date was vaccinated with Gardasil (lot# unknown).  "The patient came in on 24-DEC-2007 to receive a dose of Gardasil, but when she arrived at the office they found out the patient was pregnant, but the date of gestation was unspecified by the reporter.  The nurse reported that they did not give the dose of Gardasil the patient was supposed to receive another dose of Gardasil, but what dose was unspecified by the reporter.  No further AE information was given.  Medical attention was sought.  The estimated date of delivery was unknown.  Follow-up information was received.  The patient's name was updated.  It was reported that the patient had a miscarriage.  The physician does not think it was caused by Gardasil.  Upon internal review miscarriage is considered to be an other medical event (OME).  Follow-up information was received on from a registered nurse on 22-JAN-2008.  It was reported that the patient did not have a miscarriage it was planned termination of the fetus by the patient.  Upon internal review abortion induced is considered to be an other medical event. Additional information has been requested.
Patient was supposed to receive Hepatitis B vaccination. However patient inadvertently received the DTaP vaccination. It is one month earlier than it was originally supposed to be administered.  Called and spoke to CDC hotline.   They report that there should be no adverse reaction.
Information was received from a registered nurse who reported that multiple unspecified patients with an unknown ages and genders. The patients' pertinent medical history or concurrent conditions were not provided. On an unknown dates, the patients were vaccinated with multiple doses of an incorrect storage of PEDVAXHIB (Lot # M001813, exp. 14-OCT-2018, lot # M014925, exp. 16-FEB-2019, lot # M020102, exp. 03-FEB-2019) (route, anatomical location and dose were not reported) for prophylaxis. No adverse effects were reported.  No other information was provided. Temperature excursion was 33.1 F for 90 minutes as per data logger. This is one of several reports received from the same reporter. As of 27-DEC-2016, all telephone attempts to obtain follow up information have been unsuccessful. Additional information has been requested. Sender's Comments: US-009507513-1701USA001215: US-009507513-1610USA006216: US-009507513-1701USA001214.
This spontaneous report was received from a Healthcare Worker refers to a patient of unknown age. On 18-OCT-2013 the patient received an expired dose of GARDASIL (lot#: 0837AA, expired on 11-OCT-2013) (intramuscular route; dose not reported). No known adverse effects. Additional information has been requested.
I noticed when I was talking, my voice was feeling tired. 2 or 3 days later, on a work call, I went to say something and nothing would come out. I just didn't talk for a few days. I went a couple of weeks with no improvement.  I went to my doctor and was put on antibiotics but still no improvement. My doctor referred me to a specialists who then referred me to a voice specialists for one visit. I did exercises and slowly I could feel the improvement about a month after.
This case was reported by a physician via sales rep and described the occurrence of neck pain in a female patient who received BEXSERO. Concomitant products included HAVRIX pediatric. On an unknown date, the patient received BEXSERO at an unknown dose. On an unknown date, an unknown time after receiving BEXSERO, the patient experienced neck pain (serious criteria other: as per reporter) and migraine (serious criteria other: as per reporter). On an unknown date, the outcome of the neck pain and migraine were unknown. The reporter considered the neck pain and migraine to be almost certainly related to BEXSERO. Additional details were reported as follows: The age at vaccination was not reported. The physician stated about two female patient that after being administered BEXSERO vaccine, they ended up in the emergency room. Both the patients experienced with severe neck pain and one of the patients had as migraine as well. This case concerned the patient who had experienced severe neck pain and migraine after vaccination. The sales representative had extremely limited information. One female patient was 18 years old and the other female patient was 16 years old. One of the patients were administered HAVRIX with BEXSERO, but the sales representative did not know which patient.
My body no effect, my body is bad, very bad. Similar I have a Covid.; inflammation; Terrible, I felt so bad.; Fever; headache; pain and pain in my arm.; I got pain in my body, in my shoulder, in my arm; I got pain in my body, in my shoulder, in my arm; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;  Solution for injection; Lot Number: unknown) via an unspecified route of administration on 03Apr2021 as a single dose for covid-19 immunization. The patient's medical history included Covid (last year in June) and concomitant medications were not reported. On an unspecified date, the patient stated, "I take the first vaccine in April 3 and I effect, secondary effect last and no finish. Fever, headache, pain and pain in my arm. Pain and inflammation. Today is fourth day that they gave me the vaccine. Terrible, I felt so bad, all my body my hair. I am waiting everyday for stay fine, I know that's no good for me the vaccine in my body." When confirmed the vaccine as Pfizer's Covid vaccine, consumer stated, No, the first. I am having second effect. When probed for the effects, consumer stated, "I got the second effect from the vaccine. No reaction, no good. I got pain in my body, in my shoulder, in my arm." When probed if consumer had a query, consumer stated, "I called and respond a report second effect because no finish the second effect continue 5 days. Days today 5 days." Nobody respond It's just terrible, don't know what happen. My body no effect, my body was bad, very bad. Similar I have a Covid, I have Covid last year in June, was the similar." as reported by reporter. Outcome of the event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
The vaccine was administered in my left arm, but my right hand started feeling numb.  It only lasted about 30 mins and I was able to drive home, but it was very weird and unexpected.
The patient experienced a migraine headache, fever, stuffiness, felt hot and her head, neck and chest aches. The patient's right arm is sore at the site of injection. The patient had nausea and vomited on 11/06 and remained ill until 11/08.
Chills; fever; headache; body aches; injection site and upper arm soreness; injection site and upper arm soreness; extreme fatigue; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 47-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 19Oct2021 15:45 (Lot number: ff8839) at the age of 47 years as dose 1, single for covid-19 immunization.   Relevant medical history included: "Migraines" (unspecified if ongoing); "Penicillin" (unspecified if ongoing). Concomitant medication(s) included: RELPAX; ADVIL [IBUPROFEN]; TIZANIDINE.  The following information was reported: CHILLS (non-serious) with onset 19Oct2021 18:45, outcome "not recovered", described as "Chills"; PYREXIA (non-serious) with onset 19Oct2021 18:45, outcome "not recovered", described as "fever"; HEADACHE (non-serious) with onset 19Oct2021 18:45, outcome "not recovered", described as "headache"; PAIN (non-serious) with onset 19Oct2021 18:45, outcome "not recovered", described as "body aches"; VACCINATION SITE PAIN (non-serious), PAIN IN EXTREMITY (non-serious) all with onset 19Oct2021 18:45, outcome "not recovered" and all described as "injection site and upper arm soreness"; FATIGUE (non-serious) with onset 19Oct2021 18:45, outcome "not recovered", described as "extreme fatigue". Therapeutic measures were not taken as a result of chills, pyrexia, headache, pain, vaccination site pain, pain in extremity, fatigue.  Additional information: The patient did not receive any other vaccine in four weeks. She had covid prior to vaccination. She was not tested for covid post vaccination. She had no known allergies.  Follow-up attempts were completed. No further information is expected.
Patient experienced a bruising on the site of injection a few days after receiving the injection. Bruising became larger and darker and is still apparent 7 days after getting the vaccination.  There is no bleeding, no fever, and no pain. But the bruising have not subsided.
Patient started experiencing joint pain/inflammation approximately 4 hrs after shot. It was difficult to move arm/sleep for approximately 6 days.
While waiting, my left hand became hot. At the moment, I have pain in the shot area and below it.
Ran fever from 03/24/2019- 03/26/2019.  Covered in rash from neck to upper thighs (front & back) on 03/27/2019.  Irritable Bowel started shortly after off & on for 3 months.  Intense stomach pains & vomiting off & on for 3 weeks.
Pt syncope a few minutes after receiving vaccine. Pt continuous to feel nauseous and a little bit dizzy 20 min after receiving vaccine.
I waited 15 min and my arm felt tingly, but I didn't think much of it b/c it was cold. It hurt like a normal shot. Around day 14, I noticed a rash that was about 2 in x 1 in. I asked my provider about putting anything on it, but she said not. It lasted about 3 days and resolved. Had 2nd dose and experienced basic symptoms.
Headache since second injection also had mild headache with first Injection but eventually went away not so much this time around
Nurse was administering Covid vaccines at the local Nursing home and their staff was taking this nurse to the residents to administer the vaccine and took this nurse to the wrong resident. Nurse administered the Covid vaccine to the resident and later that evening the Nursing home called our Administrator, and informed her of the incident, taking responsibility for the incident. They had completed all of the paperwork prior vaccines being given.
Rash; Pruritus; urticaria - information has been received from a registered nurse concerning a 42 year old male, who was vaccinated with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live second generation 636921/1181k.  Subsequently, the patient experienced a rash on both legs (inner calves), with welts and itching which lasted 7 days.  Unspecified medical attention was sought.  Subsequently, the patient recovered from the rash, welts, and itching
pt recv vax & 10 to 14 days p/vax pt devel a rash @ inj site & other parts of body;
Pt's sister alerted resource RNs that her brother was feeling flush. Resource RNs arrived to the pt's side at 1309. Pt stated that he felt flush, warm/sweaty, and that his L arm was sore which was the arm that the vaccine was administered into at 1245. Water was given to the pt and vital signs were immediately taken and are as follows: BP-168/96, HR-98, O2-95%. The administration site was assessed and appeared normal. Additional assessment questions were asked to the pt regarding how he was feeling. Pt stated after vitals that he was beginning to feel better. Resource RNs stood with pt for a few more minutes until the pt stated that he was feeling completely better. Pt states that he had flu like symptoms with the first dose and that he is predicting that he will feel these same things again. Resource RNs educated pt on symptoms that warrant a call to his PCP or a trip to a medical provider. Resource RNs also advised the pt to call the health department in the event he has any adverse reactions to the vaccine. Pt then walked away with his sister.
Coking sensation, sore throat, chest pain, 0.2ml Epinephrine 1 tsp Orapred.
Few minutes after (IM) shots - felt dizzy, became pale. Normal respiration, conscious coherent. HR strong 72 BP (NL) offered supine position. Gradually recovered - up next 15 - 30 min. No complaints total time observe 30 min after recovery.
Developed sroeness at injection site; nocturnal nasal congestion; This is a spontaneous report from a contactable pharmacist. A 64-year-old male patient received bnt162b2 (BNT162B2, solution for injection, Lot #;EL3247), dose 1 via an unspecified route of administration, administered in Arm Right on 17Feb2021 11:45 as SINGLE DOSE for covid-19 immunisation. Medical history included blood cholesterol increased from an unknown date and unknown if ongoing, vasomotor rhinitis from an unknown date and unknown if ongoing, benign prostatic hyperplasia from an unknown date and unknown if ongoing, dry eye from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. On 17Feb2021 18:30, the patient experienced developed sroeness at injection site, nocturnal nasal congestion. The action taken in response to the event for bnt162b2 was not applicable. Therapeutic measures were taken as a result of developed sroeness at injection site (vaccination site pain), nocturnal nasal congestion (nasal congestion). The outcome of the event was recovering.
no further AE information reported; administration of improperly stored vaccines; This spontaneous report was received from a medical assistant and refers to a 4-year-old patient of unknown gender. No information regarding the patient's medical history, concurrent conditions, concomitant medications and previous drug reactions or allergies was reported.  On 27-AUG-2020, the patient was vaccinated with measles, mumps, rubella and varicella virus vaccine live rHA (recombinant human albumin) (PROQUAD) lot # S021326 was verified to be valid, expiration date reported and established as 05-JAN-2021 (strength, dose, frequency and route of administration were not provided) for prophylaxis. The vaccine was reconstituted with a properly stored sterile diluent.  The administered dose of vaccine experienced a temperature excursion of 6 to 14 Fahrenheit degrees (10.56 Fahrenheit degrees) for 50 minutes. There was also a previous temperature excursion of 6 to 14 Fahrenheit degrees (8.47 Fahrenheit degrees) for 30 minutes. Digital Data Logger was involved.  The patient did not experience any additional adverse reactions.
This spontaneous case reported by a consumer, describes the occurrence of pruritic rash (this rash isn't red but it's in different parts of my face and it itches) and rash (this rash isn't red but it's in different parts of my face) in a female patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received a dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced pruritic rash (this rash isn't red but it's in different parts of my face and it itches) and rash (this rash isn't red but it's in different parts of my face). At the time of the report, pruritic rash (this rash isn't red but it's in different parts of my face and it itches) and rash (this rash isn't red but it's in different parts of my face) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. Reporter did not allow further contact.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 31-year-old male patient received BNT162b2 (BNT162B2), on 06Oct2021 at 13:00 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 30 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient received Paxlovid from 27Jun2022 to 01Jul2022 for COVID-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
severe debilitating backache; could not walk; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (severe debilitating backache) and GAIT DISTURBANCE (could not walk) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced BACK PAIN (severe debilitating backache) and GAIT DISTURBANCE (could not walk). The patient was treated with PREDNISONE ongoing since an unknown date at an unspecified dose and frequency. In February 2021, BACK PAIN (severe debilitating backache) and GAIT DISTURBANCE (could not walk) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication details were not reported by the reporter.